17. RELATED PARTY BALANCES AND TRANSACTIONS The table below sets forth the major related parties and their relationships with the Group for the six months ended June 30, 2026 and 2025:
|
|
|
Name of related parties |
|
Relationships with the Group |
ABio-X Holdings, Inc. |
|
A wholly-owned subsidiary of C-Bridge V Investment Holding Limited, which is a wholly-owned subsidiary of C-Bridge Healthcare Fund V, L.P. C-Bridge Healthcare Fund V, L.P. and its affiliates hold more than 15% of the total outstanding shares of the Company. |
Everest Medicines (Singapore) Pte. Ltd |
|
A subsidiary of Everest Medicines Limited, one of Group’s principal shareholders. |
AffaMed Therapeutics (HK) Limited |
|
An affiliate of CBC Group, one of the Group’s principal shareholders. |
C-Bridge Joint Value Creation (HK) Limited |
|
A subsidiary of CBC Group, one of the Group’s principal shareholders. |
The following table summarizes the Group’s major transactions with related parties for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, |
|
|
|
|
2026 |
|
|
2025 |
|
Services received from related parties: |
|
|
|
|
|
AffaMed Therapeutics (HK) Limited |
|
R&D service fee charged for Visara |
$ |
16 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
ABio-X Holdings, Inc. |
|
Business development and related services |
|
466 |
|
|
|
55 |
|
C-Bridge Joint Value Creation (HK) Limited |
|
Consulting services |
|
94 |
|
|
|
— |
|
Total services received from related parties |
$ |
576 |
|
|
$ |
55 |
|
|
|
|
|
|
|
|
|
The following table summarizes the amounts due to related parties for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
ABio-X Holdings, Inc. |
|
Accruals and other payables |
$ |
26 |
|
|
$ |
1,131 |
|
C-Bridge Joint Value Creation (HK) Limited |
|
Accruals and other payables |
|
94 |
|
|
|
— |
|
Total accruals and other payables to related parties |
|
|
$ |
120 |
|
|
$ |
1,131 |
|
|